In the present review we will briefly discuss the current knowledge of ALK-positive advanced non-small cell lung cancer.
In the following sections, we will discuss the current knowledge on regulation of Notch signaling by TLR ligands and by inflammatory cytokines respectively.
The focus of this review is to discuss the current knowledge on the immune checkpoint molecules, PD-1/PD-L1 sinflammationflandation, and non-coding RNAs in neuRNAsastoma.
In this review, we discuss the current knowledge of genomics, metabolomics and metabolic engineering of the prevalent Lactobacillus species associated with the production of fermented dairy foods.
For each stage, we discuss the current knowledge on biological, physiological, and physical factors that influence nanoparticle transit through that stage of transcytosis, with implications for nanoparticle design.
In this review, we discuss the current knowledge on carotenoid biosynthetic pathways and genetic engineering of carotenoids to improve their nutritional value.
This review will discuss the current knowledge of this class of enzymes in mice and humans with emphasis on physiological functions of carboxylesterases in lipid metabolism and human diseases.
We shall discuss the current knowledge regarding modifications of chromatin components during the progression of progenitors into myelinating cells and discuss the potential contribution of histone variants, microRNAs, and DNA methylation.
We then discuss the current knowledge of how a cell can interact with a substrate at the nanoscale and the effect of size, morphology, organization and separation of nanofeatures on cell response.
In this review, we discuss the current knowledge on NKG2D and its ligands in the context of autoimmune diseases and immune-mediated diseases that inadvertently target endogenous cells and/or tissue.
